SURGEPAYS INC SURG
ASignal's systematic analysis rates SURG as Bearish.
Reflects the latest available analysis · analyzed Nov 18, 2026
The case on SURG
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- High revenue growth (40.7% YoY)
- Low PEG ratio (0.48x) suggesting potential undervaluation relative to growth
- RSI near oversold level (30.67), possible reversal candidate
- EV/Revenue of 0.34x indicates low enterprise value relative to sales
- Negative net, operating, and gross margins
- Negative return on assets (-122.77%)
- MACD below signal line with negative histogram
- Price below SMA20 and SMA50, indicating downtrend
- Current ratio (0.19x) and quick ratio (0.14x) signal liquidity concerns
- Negative operating cash flow ($-15.39M) and free cash flow ($-624,030)
See the full verdict on SURG
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes SURG
Most investors never get a second opinion, let alone several. ASignal runs SURG past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.